263 related articles for article (PubMed ID: 20697343)
1. Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down's syndrome.
De Vita S; Canzonetta C; Mulligan C; Delom F; Groet J; Baldo C; Vanes L; Dagna-Bricarelli F; Hoischen A; Veltman J; Fisher EM; Tybulewicz VL; Nizetic D
Oncogene; 2010 Nov; 29(46):6102-14. PubMed ID: 20697343
[TBL] [Abstract][Full Text] [Related]
2. The impact of trisomy 21 on foetal haematopoiesis.
Roberts I; O'Connor D; Roy A; Cowan G; Vyas P
Blood Cells Mol Dis; 2013 Dec; 51(4):277-81. PubMed ID: 23932236
[TBL] [Abstract][Full Text] [Related]
3. [The investigation of hematopoietic capacity of HPP-CFC derived from murine embryonic stem cells in vitro and in vivo].
Liu B; Hou CM; Wu Y; Zhang SX; Mao N
Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):312-6. PubMed ID: 15969013
[TBL] [Abstract][Full Text] [Related]
4. Early lineage priming by trisomy of Erg leads to myeloproliferation in a Down syndrome model.
Ng AP; Hu Y; Metcalf D; Hyland CD; Ierino H; Phipson B; Wu D; Baldwin TM; Kauppi M; Kiu H; Di Rago L; Hilton DJ; Smyth GK; Alexander WS
PLoS Genet; 2015 May; 11(5):e1005211. PubMed ID: 25973911
[TBL] [Abstract][Full Text] [Related]
5. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.
Kirsammer G; Jilani S; Liu H; Davis E; Gurbuxani S; Le Beau MM; Crispino JD
Blood; 2008 Jan; 111(2):767-75. PubMed ID: 17901249
[TBL] [Abstract][Full Text] [Related]
6. Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome.
Reynolds LE; Watson AR; Baker M; Jones TA; D'Amico G; Robinson SD; Joffre C; Garrido-Urbani S; Rodriguez-Manzaneque JC; Martino-Echarri E; Aurrand-Lions M; Sheer D; Dagna-Bricarelli F; Nizetic D; McCabe CJ; Turnell AS; Kermorgant S; Imhof BA; Adams R; Fisher EM; Tybulewicz VL; Hart IR; Hodivala-Dilke KM
Nature; 2010 Jun; 465(7299):813-7. PubMed ID: 20535211
[TBL] [Abstract][Full Text] [Related]
7. Haematopoietic development and leukaemia in Down syndrome.
Roberts I; Izraeli S
Br J Haematol; 2014 Dec; 167(5):587-99. PubMed ID: 25155832
[TBL] [Abstract][Full Text] [Related]
8. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome.
Bercovich D; Ganmore I; Scott LM; Wainreb G; Birger Y; Elimelech A; Shochat C; Cazzaniga G; Biondi A; Basso G; Cario G; Schrappe M; Stanulla M; Strehl S; Haas OA; Mann G; Binder V; Borkhardt A; Kempski H; Trka J; Bielorei B; Avigad S; Stark B; Smith O; Dastugue N; Bourquin JP; Tal NB; Green AR; Izraeli S
Lancet; 2008 Oct; 372(9648):1484-92. PubMed ID: 18805579
[TBL] [Abstract][Full Text] [Related]
9. Mapping the cellular origin and early evolution of leukemia in Down syndrome.
Wagenblast E; Araújo J; Gan OI; Cutting SK; Murison A; Krivdova G; Azkanaz M; McLeod JL; Smith SA; Gratton BA; Marhon SA; Gabra M; Medeiros JJF; Manteghi S; Chen J; Chan-Seng-Yue M; Garcia-Prat L; Salmena L; De Carvalho DD; Abelson S; Abdelhaleem M; Chong K; Roifman M; Shannon P; Wang JCY; Hitzler JK; Chitayat D; Dick JE; Lechman ER
Science; 2021 Jul; 373(6551):. PubMed ID: 34244384
[TBL] [Abstract][Full Text] [Related]
10. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
[TBL] [Abstract][Full Text] [Related]
11. The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF.
Pearson S; Sroczynska P; Lacaud G; Kouskoff V
Development; 2008 Apr; 135(8):1525-35. PubMed ID: 18339678
[TBL] [Abstract][Full Text] [Related]
12. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
Cooper S; Guo H; Friedman AD
PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
[TBL] [Abstract][Full Text] [Related]
13. DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome.
Canzonetta C; Mulligan C; Deutsch S; Ruf S; O'Doherty A; Lyle R; Borel C; Lin-Marq N; Delom F; Groet J; Schnappauf F; De Vita S; Averill S; Priestley JV; Martin JE; Shipley J; Denyer G; Epstein CJ; Fillat C; Estivill X; Tybulewicz VL; Fisher EM; Antonarakis SE; Nizetic D
Am J Hum Genet; 2008 Sep; 83(3):388-400. PubMed ID: 18771760
[TBL] [Abstract][Full Text] [Related]
14. Pattern of malignant disorders in individuals with Down's syndrome.
Hasle H
Lancet Oncol; 2001 Jul; 2(7):429-36. PubMed ID: 11905737
[TBL] [Abstract][Full Text] [Related]
15. Hematological changes in Down's syndrome.
Ganick DJ
Crit Rev Oncol Hematol; 1986; 6(1):55-69. PubMed ID: 2946491
[TBL] [Abstract][Full Text] [Related]
16. Endothelial to haematopoietic transition contributes to pulmonary arterial hypertension.
Liang OD; So EY; Egan PC; Goldberg LR; Aliotta JM; Wu KQ; Dubielecka PM; Ventetuolo CE; Reginato AM; Quesenberry PJ; Klinger JR
Cardiovasc Res; 2017 Nov; 113(13):1560-1573. PubMed ID: 29016733
[TBL] [Abstract][Full Text] [Related]
17. CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis.
Sarrou E; Richmond L; Carmody RJ; Gibson B; Keeshan K
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32549410
[TBL] [Abstract][Full Text] [Related]
18. Concomitant aberrant overexpression of RUNX1 and NCAM in regenerating bone marrow of myeloid leukemia of Down's syndrome.
Langebrake C; Klusmann JH; Wortmann K; Kolar M; Puhlmann U; Reinhardt D
Haematologica; 2006 Nov; 91(11):1473-80. PubMed ID: 17043020
[TBL] [Abstract][Full Text] [Related]
19. Biomechanical forces promote embryonic haematopoiesis.
Adamo L; Naveiras O; Wenzel PL; McKinney-Freeman S; Mack PJ; Gracia-Sancho J; Suchy-Dicey A; Yoshimoto M; Lensch MW; Yoder MC; García-Cardeña G; Daley GQ
Nature; 2009 Jun; 459(7250):1131-5. PubMed ID: 19440194
[TBL] [Abstract][Full Text] [Related]
20. Increase of hematopoietic progenitor and suppression of endothelial gene expression by Runx1 expression during in vitro ES differentiation.
Sakai E; Kitajima K; Sato A; Nakano T
Exp Hematol; 2009 Mar; 37(3):334-45. PubMed ID: 19218012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
